Bridge to transplantation: current outcomes.
The use of implantable ventricular assist devices for the treatment of advanced, decompensated heart failure as a bridge to heart transplantation has experienced considerable evolution over the past decade. Improvements in the management and prevention of serious adverse events, and introduction of new continuous-flow rotary pumps that are smaller, more durable, and associated with fewer serious adverse advents has expanded the use of this therapy to a larger population of patients for bridge to transplant indication.
Aggarwal
Sanjeev
S
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky, USA.
Pagani
Francis D
FD
D006333:Heart Failure / Q000601:surgery*; D016027:Heart Transplantation / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D006353:Heart-Assist Devices / Q000009:adverse effects / Q000706:statistics & numerical data*; D006801:Humans; D012770:Shock, Cardiogenic / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome